X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DISHMAN PHARMA UNICHEM LAB/
DISHMAN PHARMA
 
P/E (TTM) x 281.7 25.1 1,122.7% View Chart
P/BV x 0.6 3.3 19.3% View Chart
Dividend Yield % 2.6 0.7 393.7%  

Financials

 UNICHEM LAB   DISHMAN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
DISHMAN PHARMA
Mar-16
UNICHEM LAB/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs382374 102.0%   
Low Rs234129 181.6%   
Sales per share (Unadj.) Rs116.3197.8 58.8%  
Earnings per share (Unadj.) Rs-18.921.2 -89.2%  
Cash flow per share (Unadj.) Rs-11.734.7 -33.8%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %1.60.8 204.2%  
Book value per share (Unadj.) Rs381.0179.9 211.8%  
Shares outstanding (eoy) m70.3480.69 87.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.3 208.2%   
Avg P/E ratio x-16.311.9 -137.2%  
P/CF ratio (eoy) x-26.27.2 -362.0%  
Price / Book Value ratio x0.81.4 57.8%  
Dividend payout %-26.49.4 -280.2%   
Avg Mkt Cap Rs m21,66820,306 106.7%   
No. of employees `0002.30.8 275.0%   
Total wages/salary Rs m2,0065,355 37.5%   
Avg. sales/employee Rs Th3,587.819,252.7 18.6%   
Avg. wages/employee Rs Th880.06,459.5 13.6%   
Avg. net profit/employee Rs Th-583.72,064.1 -28.3%   
INCOME DATA
Net Sales Rs m8,18015,961 51.3%  
Other income Rs m610265 229.9%   
Total revenues Rs m8,79016,226 54.2%   
Gross profit Rs m-1,3204,103 -32.2%  
Depreciation Rs m5051,091 46.3%   
Interest Rs m80944 8.5%   
Profit before tax Rs m-1,2952,334 -55.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -200.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m33624 5.4%   
Profit after tax Rs m-1,3311,711 -77.8%  
Gross profit margin %-16.125.7 -62.8%  
Effective tax rate %-2.626.7 -9.7%   
Net profit margin %-16.310.7 -151.8%  
BALANCE SHEET DATA
Current assets Rs m23,31811,018 211.6%   
Current liabilities Rs m4,6359,517 48.7%   
Net working cap to sales %228.49.4 2,428.7%  
Current ratio x5.01.2 434.5%  
Inventory Days Days122110 110.2%  
Debtors Days Days12135 348.7%  
Net fixed assets Rs m8,16316,304 50.1%   
Share capital Rs m141161 87.2%   
"Free" reserves Rs m26,66012,907 206.6%   
Net worth Rs m26,80114,516 184.6%   
Long term debt Rs m34,189 0.1%   
Total assets Rs m31,89029,805 107.0%  
Interest coverage x-15.23.5 -437.1%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.30.5 47.9%   
Return on assets %-3.98.9 -44.0%  
Return on equity %-5.011.8 -42.1%  
Return on capital %-4.517.5 -25.9%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m4,3564,952 88.0%   
Fx outflow Rs m0697 0.0%   
Net fx Rs m4,3564,255 102.4%   
CASH FLOW
From Operations Rs m-1,1232,786 -40.3%  
From Investments Rs m16,487-1,529 -1,078.3%  
From Financial Activity Rs m-8,811-941 936.3%  
Net Cashflow Rs m6,552316 2,070.8%  

Share Holding

Indian Promoters % 50.1 61.4 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.7 408.1%  
FIIs % 3.0 12.7 23.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 22.1 143.4%  
Shareholders   20,176 46,261 43.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   GSK PHARMA  JUBILANT LIFE SCIENCES  BIOCON LTD  PIRAMAL ENTERPRISES  NATCO PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 22, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - WOCKHARDT LTD. COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS